- Epidemiology of HBV in older patients
- Assessing treatment candidacy in older patients with HBV or HBV/HDV coinfection
- Selection of first-line treatment of HBV and HDV in older patients
- Ongoing monitoring of older patients on treatment
- HBV prevention strategies
- Audience question and answer session
Date / Time
Graham R. Foster, FRCP, PhD
Professor of Hepatology
The Liver Unit
Queen Mary University of London
London, United Kingdom
Nancy Reau, MD
Professor of Medicine
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
The goal of this activity is to improve healthcare professionals’ competence in providing individualized management of HBV among older patients.
This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who provide care for older patients with chronic HBV infection.
Upon completion of this activity, participants should be able to:
- Assess HBV disease stage and treatment candidacy in older individuals with chronic HBV infection or HBV/HDV coinfection
- Implement individualized treatment strategies for older patients with chronic HBV infection or HBV/HDV coinfection, taking account of comorbidities and comedications
- Appropriately monitor and modify HBV therapy in older patients who are experiencing comorbidities associated with aging
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Designation of Credit
CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.
Continuing Pharmacy Education
CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-229-L01-P
Type of Activity: Application
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.